Literature DB >> 9705913

The human immunodeficiency virus type 1 Nef protein binds the Src-related tyrosine kinase Lck SH2 domain through a novel phosphotyrosine independent mechanism.

H Dutartre1, M Harris, D Olive, Y Collette.   

Abstract

Primate lentiviruses encode for an unique nef gene with an essential function in both viral replication and pathogenicity in the host. The molecular basis for this function remains however poorly defined. Several Nef-binding cellular proteins are thought to be instrumental in its function. Indeed, Nef contains a proline-rich motif implicated in the binding to the Src-like tyrosine kinase Hck and also to a Ser/Thr kinase of molecular weight 62 kDa. The disruption of this motif affects the binding to both these kinases as well as viral replication. Whereas Hck is expressed in the myeloid lineage and hence may account for the nef function in infected monocytes, we and others have reported previously that Nef also interacts with the T-lymphocyte Src-kinase Lck, leading to specific cell signaling impairment. This interaction occurs through the binding of Nef to both Lck SH2 and SH3 domains. Both the proline motif and phosphorylation of Nef on tyrosine residue were proposed to account for these interactions. Here, we investigate the mechanism of Lck SH2 binding by HIV-1 Nef. Using recombinant fusion proteins to precipitate lysates, we show that although SH2 binding is dependent on phosphorylation events, it occurs in a tyrosine independent manner because it requires neither tyrosine residues in Nef nor the phosphotyrosine binding pocket from the Lck SH2 domain, hence suggesting a role for a phosphoserine or a phosphothreonine residue. Further, we show that Hck SH2 does not interact with Nef, indicating that Hck SH3 binding is sufficient for Nef binding, whereas Lck SH2 cooperate together with SH3 to allow Nef binding to a level similar to Hck SH3. Together, our results establish different mechanisms for Hck and Lck binding by HIV-1 Nef protein, and identify a novel mechanism for Src-like tyrosine kinase targeting by a viral protein.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9705913     DOI: 10.1006/viro.1998.9244

Source DB:  PubMed          Journal:  Virology        ISSN: 0042-6822            Impact factor:   3.616


  12 in total

Review 1.  HIV-1 Nef control of cell signalling molecules: multiple strategies to promote virus replication.

Authors:  Alison L Greenway; Gavan Holloway; Dale A McPhee; Phoebe Ellis; Alyssa Cornall; Michael Lidman
Journal:  J Biosci       Date:  2003-04       Impact factor: 1.826

2.  Simian immunodeficiency virus and human immunodeficiency virus type 1 nef proteins show distinct patterns and mechanisms of Src kinase activation.

Authors:  A L Greenway; H Dutartre; K Allen; D A McPhee; D Olive; Y Collette
Journal:  J Virol       Date:  1999-07       Impact factor: 5.103

3.  The pathogenicity of human immunodeficiency virus (HIV) type 1 Nef in CD4C/HIV transgenic mice is abolished by mutation of its SH3-binding domain, and disease development is delayed in the absence of Hck.

Authors:  Z Hanna; X Weng; D G Kay; J Poudrier; C Lowell; P Jolicoeur
Journal:  J Virol       Date:  2001-10       Impact factor: 5.103

4.  GRB2 interaction with the ecotropic murine leukemia virus receptor, mCAT-1, controls virus entry and is stimulated by virus binding.

Authors:  Zeming Chen; Andrey A Kolokoltsov; Jia Wang; Shramika Adhikary; Marta Lorinczi; Lisa A Elferink; Robert A Davey
Journal:  J Virol       Date:  2011-11-16       Impact factor: 5.103

5.  HIV-1 Nef selectively activates Src family kinases Hck, Lyn, and c-Src through direct SH3 domain interaction.

Authors:  Ronald P Trible; Lori Emert-Sedlak; Thomas E Smithgall
Journal:  J Biol Chem       Date:  2006-07-18       Impact factor: 5.157

6.  Inhibition of Kaposi's sarcoma-associated herpesvirus lytic replication by HIV-1 Nef and cellular microRNA hsa-miR-1258.

Authors:  Qin Yan; Xinting Ma; Chenyou Shen; Xu Cao; Ninghan Feng; Di Qin; Yi Zeng; Jianzhong Zhu; Shou-Jiang Gao; Chun Lu
Journal:  J Virol       Date:  2014-02-19       Impact factor: 5.103

7.  Inhibition of human immunodeficiency virus type 1 by triciribine involves the accessory protein nef.

Authors:  Roger G Ptak; Brian G Gentry; Tracy L Hartman; Karen M Watson; M Clayton Osterling; Robert W Buckheit; Leroy B Townsend; John C Drach
Journal:  Antimicrob Agents Chemother       Date:  2010-01-19       Impact factor: 5.191

8.  Proline isomerization preorganizes the Itk SH2 domain for binding to the Itk SH3 domain.

Authors:  Andrew Severin; Raji E Joseph; Scott Boyken; D Bruce Fulton; Amy H Andreotti
Journal:  J Mol Biol       Date:  2009-02-12       Impact factor: 5.469

9.  SH2-dependent autophosphorylation within the Tec family kinase Itk.

Authors:  Raji E Joseph; Andrew Severin; Lie Min; D Bruce Fulton; Amy H Andreotti
Journal:  J Mol Biol       Date:  2009-06-11       Impact factor: 5.469

10.  Phosphotyrosine recognition domains: the typical, the atypical and the versatile.

Authors:  Tomonori Kaneko; Rakesh Joshi; Stephan M Feller; Shawn Sc Li
Journal:  Cell Commun Signal       Date:  2012-11-07       Impact factor: 5.712

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.